Evidence map›Paper›PMID 40877986›Full record

ArticleStem cell research & therapy2025

Donor-dependent regulation of type II and X collagen deposition by early modulation of miR-335-5p and miR-1246 during chondrogenic commitment.

Franziska L Breulmann, Silvia A Berger, Elena Della Bella, Martin J Stoddart

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Franziska L BreulmannAO Research Institute Davos, Clavadelerstrasse 8, Davos Platz, 7270, Switzerland.ORCID http://orcid.org/0000-0002-4162-1642
Silvia A BergerAO Research Institute Davos, Clavadelerstrasse 8, Davos Platz, 7270, Switzerland.
Elena Della BellaAO Research Institute Davos, Clavadelerstrasse 8, Davos Platz, 7270, Switzerland.ORCID http://orcid.org/0000-0001-5151-7390
Martin J StoddartAO Research Institute Davos, Clavadelerstrasse 8, Davos Platz, 7270, Switzerland. martin.stoddart@aofoundation.org.ORCID http://orcid.org/0000-0002-9538-1517

Funding

AO Foundation AO FoundationAO Trauma AO Trauma
6 · The paper itself

Abstract

backgroundIdentification of biomarkers to predict the risk of healing delays are of huge clinical interest since 10% of fracture patients progress to delayed or non-union. During endochondral ossification, which takes place in mechanically unstable regions, the bone regenerates through a cartilage intermediate. We previously identified miR-1246, miR-335-5p and miR-193a-5p as fracture-related biomarkers in patient serum, but they appear not to have a functional role in an in vitro model of direct ossification. However, their involvement in other processes related to fracture healing cannot be ruled out and the most common healing process in fracture repair is secondary healing by way of endochondral ossification. Therefore, this study aims to explore the role of miR-1246, miR-335-5p and miR-193a-5p during in vitro endochondral differentiation of human bone marrow-derived mesenchymal stromal cells (BMSCs).

methodsThe activity of miR-1246, miR-335-5p, and miR-193a-5p was transiently inhibited just before pellet formation and the start of chondrogenic differentiation in human BMSCs (n = 5 donors), serving as a model for early endochondral ossification. The effect of miRNA inhibition was assessed by histology (Safranin O/Fast Green), immunohistochemistry (type II and type X collagen), and gene expression analysis by bulk RNA sequencing and RT-qPCR.

resultsInhibition of miR-1246 and miR-335-5p enhanced chondrogenic and hypertrophic differentiation in BMSCs from three out of five donors, while miR-193a-5p inhibition had minimal effect. Donors were categorized as "responders" or "non-responders" based on histological and gene expression profiles. RNA sequencing and RT-qPCR identified differentially expressed genes, including a 1.6 and 1.5-fold upregulation of GDF5 and CCN5 respectively (p < 0.05) and downregulation of SKIL (fold change: 1.3, p = 0.0563) after miR-335-5p inhibition, while the same genes were unaltered by miRNA inhibition in non-responders, suggesting donor-specific responses to miRNA inhibition during early chondrogenesis.

conclusionsThese results suggest that miR-335-5p and miR-1246 have a regulatory effect on endochondral ossification, and genes regulated by miR-335-5p are involved in TGF-β signalling. The function of these miRNAs in human bone formation and repair should be further investigated to validate their potential role as prognostic markers in fracture healing.

Indexed as

ChondrogenesisCollagen Type IICollagen Type XMesenchymal Stem CellsMicroRNAsAdultCell DifferentiationCells, CulturedFemaleHumansMaleOsteogenesisCollagen Type IICollagen Type XMicroRNAsMIRN1246 microRNA, humanMIRN335 microRNA, humanBiomarkersBone healingChondrogenesisMesenchymal stem cellsMiRNANon-coding RNA

Identifiers

PMID40877986
PMCPMC12395737

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.